Pharmacological inhibition with the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also called FRAP-related protein (FRP1)) has emerged to be a promising tactic for cancer procedure that exploits synthetic lethal interactions with proteins associated with DNA injury mend, overcomes resistance to other therapies and enhances antitumour immunity. Various no... https://davidi222znv9.wikibestproducts.com/user